Advanced Proteome Therapeutics Corporation reported earnings results for the third quarter and nine months ended April 30, 2023. For the third quarter, the company reported net loss was USD 1.48 million compared to USD 0.467849 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.01 a year ago.
For the nine months, net loss was USD 1.97 million compared to net income of USD 0.835772 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to basic earnings per share from continuing operations of USD 0.02 a year ago.